Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

NCT05028062 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05028062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Recruiting
Start date
March 7, 2022
Completion date
July 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, alcoholism